TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 21311184

Group type: EXPERIMENTAL
Intervention: Oral mycophenolate mofetil (MMF) 1.0 g/day (1.5 g/day for patients >70 kg)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Intravenous cyclophosphamide (IVC) 1.0 g per pulse (0.8 g for patients <50 kg)
Number of subjects: 41
Study: 19852602

Group type: EXPERIMENTAL
Intervention: Intrusive force applied to test teeth
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control teeth (contralateral premolar)
Number of subjects: 21
Study: 16722277

Group type: EXPERIMENTAL
Intervention: 0.75% ropivacaine
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: 0.5% ropivacaine
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: 0.375% ropivacaine
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: 0.25% ropivacaine
Number of subjects: 72
Study: 14707325

Group type: EXPERIMENTAL
Intervention: Amantadine (100 mg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 11563430

Group type: EXPERIMENTAL
Intervention: Wearing disposable soft tinted contact lenses (Optima Colors lenses by Bausch & Lomb)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Not wearing the disposable soft tinted contact lenses
Number of subjects: 16
Study: 9143447

Group type: EXPERIMENTAL
Intervention: Kinetic gratings under passive viewing conditions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Uniform motion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Luminance defined gratings
Number of subjects: 0
Study: 8201490

Group type: EXPERIMENTAL
Intervention: terfenadine, 60 mg
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: chlorpheniramine, 4 mg
Number of subjects: 15

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 15
Study: 3276299

Group type: EXPERIMENTAL
Intervention: Controlled-release carbidopa-levodopa (CR-2 or CR-3)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard carbidopa-levodopa (Sinemet, 25 mg/100 mg)
Number of subjects: 20
Study: 30320138

Group type: EXPERIMENTAL
Intervention: Contact force information visible (n=35)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Contact force information blinded (n=37)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 72
Study: 29178684

Group type: EXPERIMENTAL
Intervention: Exercise intervention (2 or 3 times each week, 30 minutes per session at 65%-85% Vo2max for 12 weeks)
Number of subjects: 12
Study: 26289425

Group type: EXPERIMENTAL
Intervention: BAcPAc (Behavioural Activation plus physical activity promotion)
Number of subjects: 60

Group type: COMPARATOR
Intervention: BA (Behavioural Activation)
Number of subjects: 60
Study: 23931259

Group type: EXPERIMENTAL
Intervention: Plastic curets + cotton pellets + sterile saline (CPS)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Er:YAG laser (ERL)
Number of subjects: 17
Study: 21167330

Group type: EXPERIMENTAL
Intervention: Multi-component physical activity intervention including daily physical education with at least 10 min of jumping or strength training exercises of various intensities.
Number of subjects: 502

Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided).
Number of subjects: 502
Study: 18923235

Group type: EXPERIMENTAL
Intervention: Prasugrel
Number of subjects: 0

Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 0
Study: 21927893

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention for 9 months
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention for 2 years
Number of subjects: 28
Study: 15818098

Group type: EXPERIMENTAL
Intervention: Active impedance threshold device
Number of subjects: 230

Group type: COMPARATOR
Intervention: Sham impedance threshold device
Number of subjects: 230
Study: 14645173

Group type: EXPERIMENTAL
Intervention: Follicular fluid meiosis-activating sterol (FF-MAS)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Control solutions
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Criteria for good embryo quality
Number of subjects: 144
Study: 10594624

Group type: EXPERIMENTAL
Intervention: Foam and plastic tapes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Application on the forearm
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adding a gauze roll to the dressing
Number of subjects: 0
Study: 8576672

Group type: COMPARATOR
Intervention: Balanced technique anesthesia (Group 1)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Combined thoracic and balanced anesthesia (Group 2)
Number of subjects: 47
Study: 2363300

Group type: EXPERIMENTAL
Intervention: Temperature sensitive mutant ts1B
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Wild-type RS virus
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Temperature sensitive mutants (other than ts1B)
Number of subjects: 0
Study: 24271

Group type: EXPERIMENTAL
Intervention: Pipoxizin
Number of subjects: 12

Group type: COMPARATOR
Intervention: Hexoprenalin
Number of subjects: 12
Study: 12572377

Group type: EXPERIMENTAL
Intervention: Yishen Jiedu Recipe (YSJDR) in addition to low-protein diet and blood pressure controlling therapy
Number of subjects: 45

Group type: COMPARATOR
Intervention: Low-protein diet and blood pressure controlling therapy only
Number of subjects: 45
Study: 30110358

Group type: EXPERIMENTAL
Intervention: Interaction Competencies with Children for Teachers (ICC-T)
Number of subjects: 644
Study: 26673391

Group type: EXPERIMENTAL
Intervention: H7N9 live attenuated influenza vaccine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 25555099

Group type: EXPERIMENTAL
Intervention: WelTel text messaging intervention
Number of subjects: 20
Study: 22367325

Group type: EXPERIMENTAL
Intervention: Two-port access (TPA)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Conventional laparoscopy
Number of subjects: 63
Study: 20307166

Group type: EXPERIMENTAL
Intervention: Smoking intervention (eight-session individually administered trial)
Number of subjects: 247
Study: 18584479

Group type: EXPERIMENTAL
Intervention: Soy extract supplementation (3 Evestrel capsules, providing a total of 112.5 mg isoflavones aglycone eq/day) for 3 days before prostate surgery
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Soy extract supplementation
Number of subjects: 12
Study: 16875160

Group type: EXPERIMENTAL
Intervention: PGE1 (Prostavasin) infusion at a dose of 0.02 mg/kg b.m./min
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group (no PGE1 infusion)
Number of subjects: 54
Study: 12800417

Group type: EXPERIMENTAL
Intervention: Astragalus Injection (AI) 30 ml (equivalent to 60 g crude drug) administered intravenously once a day for 20 days
Number of subjects: 62

Group type: COMPARATOR
Intervention: Nitroglycerine injection 10 mg administered intravenously once a day for 20 days (Control group)
Number of subjects: 62
Study: 10806603

Group type: EXPERIMENTAL
Intervention: MK-852 (1 microgram/kg/min for 1 hour)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MK-852 (0.44 microgram/kg/min for 4 hours)
Number of subjects: 0
Study: 8872850

Group type: EXPERIMENTAL
Intervention: Nifedipine GITS
Number of subjects: 6592

Group type: COMPARATOR
Intervention: Co-amilozide (thiazide diuretic)
Number of subjects: 6592
Study: 1510426

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin 400 mg i.v.
Number of subjects: 12

Group type: COMPARATOR
Intervention: Ciprofloxacin oral doses (500 mg and 750 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin i.v. dosing
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (both routes)
Number of subjects: 12
Study: 6682776

Group type: EXPERIMENTAL
Intervention: Cis-diamminedichloroplatinum (II) (CDDP) at various doses (20 mg/m2, 25-50 mg/m2, 70-120 mg/m2)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Rapid infusion of a single high dose of CDDP
Number of subjects: 48

Group type: COMPARATOR
Intervention: Daily low dose of CDDP for 5 days
Number of subjects: 48

Group type: COMPARATOR
Intervention: Single low dose of CDDP
Number of subjects: 48
Study: 30450972

Group type: EXPERIMENTAL
Intervention: Dry heat treatment (fluidotherapy)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Control group (joint protection and exercise program)
Number of subjects: 93
Study: 30483718

Group type: EXPERIMENTAL
Intervention: Proplan virtual software teaching method
Number of subjects: 100

Group type: COMPARATOR
Intervention: Traditional orthognathic surgery teaching method
Number of subjects: 100
Study: 27656053

Group type: EXPERIMENTAL
Intervention: Alprazolam and Diclofenac Potassium (pre-medication)
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Gow-Gates technique with pre-medication
Number of subjects: 198

Group type: COMPARATOR
Intervention: Control group (without pre-medication)
Number of subjects: 198
Study: 24864502

Group type: EXPERIMENTAL
Intervention: Corneregel
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Solcoseryl Eye Gel
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Corneregel and low-viscosity artificial tears
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Artificial tears (preservative-free, low and high viscosity)
Number of subjects: 66
Study: 23146641

Group type: EXPERIMENTAL
Intervention: Revascularization with platelet-rich plasma (PRP)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Revascularization without platelet-rich plasma (PRP)
Number of subjects: 20
Study: 20057344

Group type: EXPERIMENTAL
Intervention: Intravitreal triamcinolone acetonide (IVTA) injection plus panretinal photocoagulation (PRP) and macular photocoagulation (MPC)
Number of subjects: 23

Group type: COMPARATOR
Intervention: PRP and MPC (control)
Number of subjects: 23
Study: 17347809

Group type: EXPERIMENTAL
Intervention: Full macular translocation (FMT)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Photodynamic therapy (PDT)
Number of subjects: 50
Study: 16123680

Group type: EXPERIMENTAL
Intervention: pegylated interferon alpha‐2b 1.5 microg/kg/wk and ribavirin 800‐1200 mg/d for 24 weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 50
Study: 12469988

Group type: EXPERIMENTAL
Intervention: Donepezil (5 mg and 10 mg once daily)
Number of subjects: 1920

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1920
Study: 10427675

Group type: EXPERIMENTAL
Intervention: Goal-directed action (reaching for preferred food)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Rote exercise (reaching to a spatial location)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Natural context (reaching to pick up the receiver of an active telephone)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Partial context (reaching to a detached receiver)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Simulated context (reaching for a stick)
Number of subjects: 14
Study: 7579555

Group type: EXPERIMENTAL
Intervention: Tropisetron, 5 mg o.d. plus dexamethasone, 12 mg i.v. on day 1 followed by 4 mg orally b.i.d. on days 2‐5
Number of subjects: 126

Group type: COMPARATOR
Intervention: Tropisetron, 5 mg o.d.
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Tropisetron plus dexamethasone
Number of subjects: 126
Study: 2181110

Group type: EXPERIMENTAL
Intervention: Coronal scaling, root planing, modified Widman surgery, and flap with osseous resectional surgery
Number of subjects: 82
Study: 6106611

Group type: EXPERIMENTAL
Intervention: Triazolam 0.25 mg
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Triazolam 0.50 mg
Number of subjects: 27

Group type: COMPARATOR
Intervention: Chloral hydrate 250 mg
Number of subjects: 27

Group type: COMPARATOR
Intervention: Chloral hydrate 500 mg
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 31277678

Group type: EXPERIMENTAL
Intervention: Local distribution acupoint (LA) group
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Local-distal acupoint (LDA) group
Number of subjects: 108

Group type: COMPARATOR
Intervention: Waiting-list (WL) group
Number of subjects: 108
Study: 29030524

Group type: EXPERIMENTAL
Intervention: Safe sleep QI intervention
Number of subjects: 8
Study: 27321790

Group type: EXPERIMENTAL
Intervention: Levosimendan (10 µg/kg bolus followed by infusion at a rate of 0.1 µg/kg/min for 24 hours)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Milrinone (50 µg/kg bolus followed by infusion at a rate of 0.5 µg/kg/min for 24 hours)
Number of subjects: 40
Study: 25118146

Group type: EXPERIMENTAL
Intervention: Guided self-determination youth intervention (GSD-Y)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Treatment as usual (control)
Number of subjects: 71
Study: 21791141

Group type: EXPERIMENTAL
Intervention: Vitamin A Supplementation (VAS)
Number of subjects: 291
Study: 19161479

Group type: EXPERIMENTAL
Intervention: Bedside Teaching (BT) followed by Computer-Based Learning (CBL)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Computer-Based Learning (CBL) followed by Bedside Teaching (BT)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Questionnaire responses
Number of subjects: 28
Study: 17156836

Group type: EXPERIMENTAL
Intervention: walking routes
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: walking in tasks
Number of subjects: 64

Group type: COMPARATOR
Intervention: control (maintain normal behaviour)
Number of subjects: 64
Study: 15831514

Group type: EXPERIMENTAL
Intervention: recombinant FSH (rFSH)
Number of subjects: 85
Study: 11977638

Group type: EXPERIMENTAL
Intervention: Amifostin (treatment group A)
Number of subjects: 193
Study: 10080444

Group type: EXPERIMENTAL
Intervention: Nasal oxygen applied by nasal prongs
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparable controls (not specified)
Number of subjects: 0
Study: 8714736

Group type: EXPERIMENTAL
Intervention: Scanning force microscopy
Number of subjects: 0
Study: 2035790

Group type: EXPERIMENTAL
Intervention: Mouth-to-mouth breathing
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Simple ventilation device
Number of subjects: 17

Group type: COMPARATOR
Intervention: Automatic ventilators
Number of subjects: 17
Study: 7268356

Group type: EXPERIMENTAL
Intervention: 400 mg sulfinpyrazone with sodium load
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control (no sulfinpyrazone)
Number of subjects: 18
Study: 30635007

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical acupoint stimulation (TEAS)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Sham TEAS
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: TEAS combined with opioid drugs
Number of subjects: 160

Group type: COMPARATOR
Intervention: Opioid drugs
Number of subjects: 160
Study: 30461602

Group type: EXPERIMENTAL
Intervention: Intravenous propofol anesthesia
Number of subjects: 186

Group type: COMPARATOR
Intervention: Inhalational sevoflurane anesthesia
Number of subjects: 186
Study: 27884128

Group type: EXPERIMENTAL
Intervention: Culturally tailored multifaceted dietary intervention
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Oral probiotic treatment (Lactobacillus rhamnosus GG and Bifidobacterium lactis BB12 at a dose of 7 × 10^9 colony-forming units one per day until birth)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Routine dietary advice
Number of subjects: 220

Group type: COMPARATOR
Intervention: Placebo capsule
Number of subjects: 220
Study: 24859367

Group type: EXPERIMENTAL
Intervention: Elastic intramedullary nail (EIN)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Precontoured dynamic compression plate
Number of subjects: 66
Study: 22648385

Group type: EXPERIMENTAL
Intervention: Breast-feeding (BRF) in SGA infants
Number of subjects: 174

Group type: COMPARATOR
Intervention: Formula-feeding (FOF) in SGA infants (standard formula - FOF1)
Number of subjects: 174

Group type: COMPARATOR
Intervention: Formula-feeding (FOF) in SGA infants (protein-rich formula - FOF2)
Number of subjects: 174

Group type: COMPARATOR
Intervention: Breast-feeding (BRF) in AGA infants
Number of subjects: 174
Study: 18835506

Group type: EXPERIMENTAL
Intervention: Glutamine (0.5 g/kg/day)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Isonitrogenous, isocaloric, isovolemic nutritional solution
Number of subjects: 78

Group type: COMPARATOR
Intervention: Physiological NaCl 0.9%
Number of subjects: 78
Study: 17635245

Group type: EXPERIMENTAL
Intervention: 0.07% cetylpyridinium chloride (CPC) mouth rinse (Crest Pro‐Health)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Essential oils (EO) mouth rinse (Listerine)
Number of subjects: 151
Study: 15234680

Group type: EXPERIMENTAL
Intervention: Hand grasp neuroprosthesis with natural sensory feedback
Number of subjects: 11

Group type: COMPARATOR
Intervention: Hand grasp neuroprosthesis without natural sensory feedback
Number of subjects: 11
Study: 12034156

Group type: EXPERIMENTAL
Intervention: Pentoxifylline 400 mg TID in addition to diuretics, digoxin, enalapril and carvedilol
Number of subjects: 59

Group type: COMPARATOR
Intervention: Conventional therapy (diuretics, digoxin, enalapril and carvedilol)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Pentoxifylline
Number of subjects: 59
Study: 12029907

Group type: EXPERIMENTAL
Intervention: Early discharge with axillary drains in situ
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard hospital stay
Number of subjects: 0
Study: 9562007

Group type: EXPERIMENTAL
Intervention: Alteplase (100 mg 2-h infusion)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Streptokinase (1.5 million IU over 2 h)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 66
Study: 7942481

Group type: EXPERIMENTAL
Intervention: Transaortic RF ablation (n = 54)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Transseptal RF ablation (n = 28)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Total RF ablation success
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Transseptal puncture/long sheath method (n = 24)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Transseptal group
Number of subjects: 73

Group type: COMPARATOR
Intervention: Transaortic group
Number of subjects: 73
Study: 3204147

Group type: EXPERIMENTAL
Intervention: Tamoxifen 30 mg administered 12 h before hCG injection and 48 h before oocyte capture
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 40
Study: 1565806

Group type: EXPERIMENTAL
Intervention: Information about a married mother client
Number of subjects: 83

Group type: COMPARATOR
Intervention: Information about an unmarried mother client
Number of subjects: 83

Group type: COMPARATOR
Intervention: Predictions of patients' behaviors and verbal responses
Number of subjects: 83
Study: 329406

Group type: EXPERIMENTAL
Intervention: 1000 IU of calciferol daily for 8 months
Number of subjects: 0
Study: 29752009

Group type: EXPERIMENTAL
Intervention: Omega-3 PUFAs (2 g daily, 8 weeks)
Number of subjects: 31
Study: 29607864

Group type: EXPERIMENTAL
Intervention: MTA Fillapex
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: EndoREZ
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: AH26
Number of subjects: 45
Study: 27620862

Group type: EXPERIMENTAL
Intervention: Five-week sensory motor training program
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (continued soccer practice sessions)
Number of subjects: 22
Study: 25137844

Group type: EXPERIMENTAL
Intervention: Acupuncture-anesthetic composite anesthesia (AACA)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Intravenous anesthesia (sufentanil combined propofol)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Acupuncture combined with intravenous anesthesia (sufentanil, propofol combined with acupuncture)
Number of subjects: 93
Study: 22207450

Group type: EXPERIMENTAL
Intervention: Acupressure with standard of care
Number of subjects: 15

Group type: COMPARATOR
Intervention: Standard of care alone
Number of subjects: 15
Study: 19067708

Group type: EXPERIMENTAL
Intervention: Pimecrolimus cream 1%
Number of subjects: 200

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Pimecrolimus cream 1% and Vehicle (control)
Number of subjects: 200
Study: 17985507

Group type: EXPERIMENTAL
Intervention: Individualized psychoeducational diabetes uncertainty management intervention (DM‐UMI) delivered via telephone for four weeks
Number of subjects: 68

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 68
Study: 16027437

Group type: EXPERIMENTAL
Intervention: Supplementation with alpha‐tocopherol (400 IU/d) and beta‐carotene (30 mg/d)
Number of subjects: 540

Group type: EXPERIMENTAL
Intervention: Supplementation with alpha‐tocopherol and beta‐carotene
Number of subjects: 540
Study: 12004847

Group type: EXPERIMENTAL
Intervention: Combination of 5‐FU (600 mg/m2 24‐hour infusion for five days, then 600 mg/m2 IV once a week) and IFN (5 MU subcutaneously three times a week for six months)
Number of subjects: 322

Group type: COMPARATOR
Intervention: Combination of leucovorin (20 mg/m2 rapid intravenous injection) and 5‐FU (425 mg/m2 IV days 1‐5 every 28 days for six cycles)
Number of subjects: 322
Study: 10457120

Group type: EXPERIMENTAL
Intervention: Loratadine (10 mg u.i.d.) plus flunisolide (two 25 microg puffs per nostril morning and night)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo plus flunisolide (two 25 microg puffs per nostril morning and night)
Number of subjects: 30
Study: 7799030

Group type: EXPERIMENTAL
Intervention: TNF/IFN/M (tumor necrosis factor, interferon gamma, and melphalan)
Number of subjects: 19

Group type: COMPARATOR
Intervention: M alone (melphalan)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: TNF/IFN/M
Number of subjects: 19
Study: 2205326

Group type: EXPERIMENTAL
Intervention: Endosonography
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Computed Tomography (CT)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging (MRI)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Examination Under Anaesthesia (EUA)
Number of subjects: 37
Study: 371643

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 8
Study: 31662539

Group type: EXPERIMENTAL
Intervention: Self-expandable metal stent positioning (Group 1, 16 patients)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Primary tumor resection (Group 2, 17 patients)
Number of subjects: 33